Fri, March 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 22, 2024
[ 12:00 AM ] - WOPRAI
Thu, November 2, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
[ 12:00 AM ] - WOPRAI
Wed, June 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 23, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 2, 2022
[ 12:00 AM ] - WOPRAI
Fri, June 17, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 24, 2022
[ 12:00 AM ] - WOPRAI
Thu, March 3, 2022
[ 12:00 AM ] - WOPRAI
Mon, February 28, 2022
[ 12:00 AM ] - WOPRAI
Tue, September 7, 2021
[ 12:00 AM ] - WOPRAI
Mon, July 26, 2021
[ 12:00 AM ] - WOPRAI
Thu, June 17, 2021
[ 12:00 AM ] - WOPRAI
Mon, June 14, 2021
[ 12:00 AM ] - WOPRAI
Tue, April 13, 2021
[ 12:00 AM ] - WOPRAI
Thu, July 30, 2020
[ 12:00 AM ] - WOPRAI
Tue, April 21, 2020
[ 12:00 AM ] - WOPRAI
Mon, March 2, 2020
[ 12:00 AM ] - WOPRAI
Mon, February 10, 2020
[ 12:00 AM ] - WOPRAI
Tue, December 17, 2019
[ 12:00 AM ] - WOPRAI
Fri, October 25, 2019
[ 12:00 AM ] - WOPRAI
Tue, October 22, 2019
[ 12:00 AM ] - WOPRAI
Mon, June 3, 2019
[ 12:00 AM ] - WOPRAI
Thu, May 2, 2019
[ 12:00 AM ] - WOPRAI
Fri, April 26, 2019
[ 12:00 AM ] - WOPRAI
Thu, December 6, 2018
[ 12:00 AM ] - WOPRAI
Thu, September 13, 2018
[ 12:00 AM ] - WOPRAI
Mon, August 6, 2018
[ 12:00 AM ] - WOPRAI
Thu, August 2, 2018
Liana Moussatos Reiterated (VRNA) at Buy and Held Target at $33 on, Mar 1st, 2024
Liana Moussatos of Wedbush, Reiterated "Verona Pharma plc" (VRNA) at Buy and Held Target at $33 on, Mar 1st, 2024.
Liana has made no other calls on VRNA in the last 4 months.
There is 1 other peer that has a rating on VRNA. Out of the 1 peers that are also analyzing VRNA, 0 agree with Liana's Rating of Hold.
This is the rating of the analyst that currently disagrees with Liana
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Monday, January 22nd, 2024
Contributing Sources